We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

ActiveSight to Provide Crystallography Services to Inpharmatica

Read time: Less than a minute

ActiveSight has announced that it has signed an agreement to provide structural biology services to Inpharmatica Ltd

The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules with a human drug target protein. The agreement includes upfront fees and payments for milestones.

"ActiveSight is delighted to augment Inpharmatica's unique drug discovery platform," stated Duncan McRee, Ph.D., President of ActiveSight.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.